PL2403505T3 - Terapeutyczne zastosowania frakcji gumy mastyksowej - Google Patents
Terapeutyczne zastosowania frakcji gumy mastyksowejInfo
- Publication number
- PL2403505T3 PL2403505T3 PL10712171T PL10712171T PL2403505T3 PL 2403505 T3 PL2403505 T3 PL 2403505T3 PL 10712171 T PL10712171 T PL 10712171T PL 10712171 T PL10712171 T PL 10712171T PL 2403505 T3 PL2403505 T3 PL 2403505T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic uses
- mastic gum
- gum fractions
- fractions
- mastic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15721509P | 2009-03-04 | 2009-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2403505T3 true PL2403505T3 (pl) | 2017-06-30 |
Family
ID=42224206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10712171T PL2403505T3 (pl) | 2009-03-04 | 2010-03-04 | Terapeutyczne zastosowania frakcji gumy mastyksowej |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8956601B2 (pl) |
| EP (1) | EP2403505B8 (pl) |
| CN (2) | CN106619700A (pl) |
| AU (1) | AU2010220056B2 (pl) |
| BR (1) | BRPI1013223A2 (pl) |
| CA (2) | CA2754564C (pl) |
| DK (1) | DK2403505T3 (pl) |
| EA (2) | EA201492259A1 (pl) |
| ES (1) | ES2617875T3 (pl) |
| HU (1) | HUE032032T2 (pl) |
| PL (1) | PL2403505T3 (pl) |
| WO (1) | WO2010100650A2 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1013222B8 (pt) * | 2009-03-04 | 2021-05-25 | Regenera Pharma Ltd | composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l. |
| CA2779025A1 (en) * | 2009-10-28 | 2011-05-05 | Regenera Pharma Ltd. | Therapeutic uses of oligomeric and polymeric monoterpenes |
| CN106924266A (zh) | 2010-09-07 | 2017-07-07 | 瑞吉纳拉制药公司 | 包含乳香的酸性提取物的组合物 |
| US20150246087A1 (en) * | 2012-06-11 | 2015-09-03 | Regenera Pharma Ltd. | Extracts and therapeutic uses thereof |
| WO2015054696A1 (en) * | 2013-10-11 | 2015-04-16 | ABSORBezz LLC | Animal health improvement composition and method |
| KR101645721B1 (ko) * | 2014-12-30 | 2016-08-05 | 대전대학교 산학협력단 | 위장질환 예방 및 치료용 유향 함유 조성물 |
| IL237621A0 (en) * | 2015-03-08 | 2015-06-30 | Regenera Pharma Ltd | Use of isolated fractions of the gum goddess to treat optic neuropathy |
| CA2999820A1 (en) | 2015-09-24 | 2017-03-30 | Regenera Pharma Ltd. | Compositions comprising triterpenoids |
| CN108289863B (zh) | 2015-09-24 | 2021-03-16 | 瑞吉纳拉制药公司 | 包含三萜类的组合物 |
| CN109922798A (zh) * | 2016-09-08 | 2019-06-21 | 瑞吉纳拉制药公司 | 包括乳香胶的酸性提取物的组合物及其用于治疗视神经病变的用途 |
| US11207333B2 (en) | 2016-09-08 | 2021-12-28 | Regenera Pharma Ltd. | Compositions comprising triterpenoids and uses thereof for treating optic neuropathy |
| KR102300227B1 (ko) * | 2021-04-08 | 2021-09-09 | 주식회사 프롬바이오 | 매스틱 검 수용액을 포함하는 탈모 방지 및 발모 촉진용 화장료 조성물 |
| KR102328824B1 (ko) * | 2021-07-12 | 2021-11-23 | 주식회사 프롬바이오 | 수용화 매스틱 검과 감태나무 추출물을 이용한 발모 촉진 또는 탈모 억제용 조성물 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374957A (en) | 1981-10-29 | 1983-02-22 | Michigan Molecular Institute | Triblock polymers of a monovinyl aromatic compound and myrcene |
| US4564718A (en) | 1984-08-14 | 1986-01-14 | The University Of Manchester Institute Of Science And Technology | Functionally terminated polymers from terpene monomers and their applications |
| US4713243A (en) | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
| JPS63179908A (ja) | 1987-01-22 | 1988-07-23 | Japan Synthetic Rubber Co Ltd | ミルセン重合体およびその製造方法 |
| DE3820218A1 (de) * | 1988-06-14 | 1989-12-28 | Osama L M Dr Med Dr Rer N Omer | Phytotherapeutikum zur behandlung von depressivem syndrom |
| US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
| US5506406A (en) | 1993-05-17 | 1996-04-09 | Atomic Energy Corporation Of South Africa Ltd. | Method and apparatus for determining the concentration of a heavy element in a rock face |
| US5759569A (en) | 1995-01-10 | 1998-06-02 | The Procter & Gamble Company | Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components |
| US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
| GR950100243A (el) | 1995-06-28 | 1997-02-28 | �. �����- �. ����� �.�.�. | Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων. |
| JPH10130254A (ja) | 1996-11-01 | 1998-05-19 | Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai | ジヒドロクマリン系化合物およびエストロゲン作用剤 |
| DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| GR1003541B (el) | 1999-05-11 | 2001-03-07 | Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι | |
| GR1003550B (el) | 1999-09-22 | 2001-03-13 | Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων | |
| US6623728B2 (en) | 2000-06-30 | 2003-09-23 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Cosmetic skin care compositions and containing gum mastic |
| US7056491B2 (en) | 2000-11-08 | 2006-06-06 | Wisconsin Alumni Research Foundation | Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators |
| GR1003868B (el) * | 2001-02-06 | 2002-04-19 | Lavipharm S.A. | Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους |
| EP1361863A2 (en) | 2001-02-13 | 2003-11-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Carotenoid-loaded liposomes |
| US6534548B1 (en) | 2001-10-02 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria |
| ATE441423T1 (de) | 2002-05-01 | 2009-09-15 | Lavipharm Sa | Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen |
| JP2004083443A (ja) | 2002-08-23 | 2004-03-18 | Hideji Watanabe | マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法 |
| JP4426527B2 (ja) | 2002-12-20 | 2010-03-03 | エクソンモービル・ケミカル・パテンツ・インク | 重合プロセス |
| JP4441487B2 (ja) | 2002-12-20 | 2010-03-31 | エクソンモービル・ケミカル・パテンツ・インク | 重合プロセス |
| US20050074509A1 (en) | 2003-10-02 | 2005-04-07 | Data Medica Padova S.P.A. | Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components |
| WO2005053812A1 (en) | 2003-12-08 | 2005-06-16 | Xylon Biotechnologies Ltd. | Plant materials extraction method |
| DE602005024773D1 (de) | 2004-03-04 | 2010-12-30 | Riken Wako | Isotaktisches 3,4-isopren-polymer |
| WO2005112967A2 (en) | 2004-05-19 | 2005-12-01 | Balfour Marketing Corp. | Anticancer activity of chios mastic gum |
| US20070292445A1 (en) | 2004-07-06 | 2007-12-20 | Transpharma Medical Ltd. | Delivery system for transdermal immunization |
| CA2574898C (en) | 2004-07-23 | 2011-12-20 | Tsung-Chung Lin | Immune modulation and anti-allergy activities of zingiber zerumbet |
| NZ555219A (en) * | 2004-11-13 | 2011-03-31 | Metaproteomics Llc | Compositions exhibiting inhibition of cyclooxygenase-2 |
| US20070036873A1 (en) | 2005-07-27 | 2007-02-15 | Shibnath Ghosal | Method of treatment or management of stress |
| US20070148187A1 (en) * | 2005-12-27 | 2007-06-28 | Intact Enterprises, Inc. | Mastic gum composition for use as a dietary supplement in humans and animals |
| CN100478335C (zh) * | 2006-11-30 | 2009-04-15 | 上海力智生化科技有限公司 | 一种环氧月桂烯的制备方法 |
| AR060847A1 (es) | 2007-05-03 | 2008-07-16 | Spannagel Lucia Antonia | Formulacion a base de calendula, aloe y centella. |
| BRPI1013222B8 (pt) | 2009-03-04 | 2021-05-25 | Regenera Pharma Ltd | composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l. |
-
2010
- 2010-03-04 EA EA201492259A patent/EA201492259A1/ru unknown
- 2010-03-04 WO PCT/IL2010/000183 patent/WO2010100650A2/en active Application Filing
- 2010-03-04 CA CA2754564A patent/CA2754564C/en active Active
- 2010-03-04 EA EA201190168A patent/EA021886B1/ru not_active IP Right Cessation
- 2010-03-04 ES ES10712171.7T patent/ES2617875T3/es active Active
- 2010-03-04 CN CN201611216078.2A patent/CN106619700A/zh active Pending
- 2010-03-04 AU AU2010220056A patent/AU2010220056B2/en not_active Ceased
- 2010-03-04 US US13/254,394 patent/US8956601B2/en active Active
- 2010-03-04 HU HUE10712171A patent/HUE032032T2/en unknown
- 2010-03-04 CA CA2974805A patent/CA2974805C/en active Active
- 2010-03-04 BR BRPI1013223A patent/BRPI1013223A2/pt not_active IP Right Cessation
- 2010-03-04 PL PL10712171T patent/PL2403505T3/pl unknown
- 2010-03-04 EP EP10712171.7A patent/EP2403505B8/en active Active
- 2010-03-04 DK DK10712171.7T patent/DK2403505T3/en active
- 2010-03-04 CN CN201080018569.0A patent/CN102413833B/zh not_active Expired - Fee Related
-
2014
- 2014-12-31 US US14/588,037 patent/US9364509B2/en active Active
-
2016
- 2016-05-13 US US15/154,698 patent/US10251923B2/en active Active
-
2019
- 2019-02-27 US US16/287,542 patent/US20190192594A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2974805A1 (en) | 2010-09-10 |
| CA2754564A1 (en) | 2010-09-10 |
| EP2403505B1 (en) | 2016-12-07 |
| US20150110902A1 (en) | 2015-04-23 |
| US20120003175A1 (en) | 2012-01-05 |
| AU2010220056B2 (en) | 2015-04-02 |
| BRPI1013223A2 (pt) | 2017-09-26 |
| CN106619700A (zh) | 2017-05-10 |
| CA2754564C (en) | 2017-09-12 |
| US20160287654A1 (en) | 2016-10-06 |
| EA021886B1 (ru) | 2015-09-30 |
| DK2403505T3 (en) | 2017-03-06 |
| HUE032032T2 (en) | 2017-09-28 |
| CN102413833B (zh) | 2017-02-08 |
| ES2617875T3 (es) | 2017-06-20 |
| US8956601B2 (en) | 2015-02-17 |
| WO2010100650A4 (en) | 2011-02-03 |
| WO2010100650A2 (en) | 2010-09-10 |
| EA201190168A1 (ru) | 2013-01-30 |
| EP2403505A2 (en) | 2012-01-11 |
| EA201492259A1 (ru) | 2015-04-30 |
| US9364509B2 (en) | 2016-06-14 |
| US20190192594A1 (en) | 2019-06-27 |
| CA2974805C (en) | 2021-11-30 |
| CN102413833A (zh) | 2012-04-11 |
| EP2403505B8 (en) | 2017-03-15 |
| AU2010220056A1 (en) | 2011-10-13 |
| US10251923B2 (en) | 2019-04-09 |
| WO2010100650A3 (en) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262567B (en) | Concentrated therapeutic phospholipid preparations | |
| HK1231408A1 (zh) | 藥物組合物 | |
| PL2403505T3 (pl) | Terapeutyczne zastosowania frakcji gumy mastyksowej | |
| ZA201200054B (en) | Therapeutic compounds and compositions | |
| HK1183802A1 (en) | Therapeutic oral composition | |
| IL214923A (en) | Compounds containing isolated sections of the gum goddess | |
| HK1174064A1 (zh) | 用於細胞增殖相關的疾病的方法和組合物 | |
| PT2482812T (pt) | Composições farmacêuticas compreendendo bi-1356 e metformina | |
| EP2406389A4 (en) | METHOD AND COMPOSITIONS FOR CELL-RETENTION-BASED DISEASES | |
| IL218212A0 (en) | Therapeutic methods and compositions | |
| EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HU0900072D0 (en) | Transdermal pharmaceutical compositions | |
| GB0808835D0 (en) | Therapeutic compositions | |
| GB0819958D0 (en) | Therapeutic compositions | |
| GB0917736D0 (en) | Gel composition | |
| EP2461870A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
| EP2460524A4 (en) | MEDICAL COMPOSITION FOR IDE IONTOPHORESIS | |
| GB0900786D0 (en) | Therapeutic compositions | |
| HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
| EP2490704A4 (en) | THERAPEUTIC COMPOSITION | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| IL214922A0 (en) | Therapeutic uses of mastic gum fractions | |
| GB0819960D0 (en) | Therapeutic composition | |
| AU2008906012A0 (en) | Therapeutic compositions |